person · Reporting owner
JENSEN MICHAEL VANGSTED
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNLOGIC, INC.SYBX · Entity 7801 | Chief Financial Officer | November 10, 2023 | November 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNLOGIC, INC.
Report date November 10, 2023 · Filed November 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.45 · Expires 2032-03-03 | Direct | 0 |
Reported balance
After 2023-11-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-11-10 · Disposition to issuer · Disposed 15,332 · Balance 0 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F2: These stock options vested 25% on the first anniversary of the March 3, 2022 grant date, and vest in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2033-03-16 | Direct | 0 |
Reported balance
After 2023-11-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-11-10 · Disposition to issuer · Disposed 13,332 · Balance 0 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F3: The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2033-03-16 | Direct | 0 |
Reported balance
After 2023-11-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-11-10 · Disposition to issuer · Disposed 6,666 · Balance 0 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F4: These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2032-03-03 | Direct | 15,332 |
Reported balance
After 2023-11-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-11-10 · Grant · Acquired 15,332 · Balance 15,332 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F2: These stock options vested 25% on the first anniversary of the March 3, 2022 grant date, and vest in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2033-03-16 | Direct | 13,332 |
Reported balance
After 2023-11-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-11-10 · Grant · Acquired 13,332 · Balance 13,332 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F3: The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2033-03-16 | Direct | 6,666 |
Reported balance
After 2023-11-10 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-11-10 · Grant · Acquired 6,666 · Balance 6,666 F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F4: These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met. |
Filing footnotes · ownership attribution and instrument terms
F1: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements.
F2: These stock options vested 25% on the first anniversary of the March 3, 2022 grant date, and vest in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F3: The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027.
F4: These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | GrantStock Option (right to buy) · Derivative | 6,666 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 6 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,666 Underlying: Common Stock · 6,666 shares Expires 2033-03-16 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F4 · derivative.exercise_date: These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | GrantStock Option (right to buy) · Derivative | 13,332 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 5 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,332 Underlying: Common Stock · 13,332 shares Expires 2033-03-16 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F3 · derivative.exercise_date: The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | GrantStock Option (right to buy) · Derivative | 15,332 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 4 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,332 Underlying: Common Stock · 15,332 shares Expires 2032-03-03 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F2 · derivative.exercise_date: These stock options vested 25% on the first anniversary of the March 3, 2022 grant date, and vest in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | Disposition to issuerStock Option (right to buy) · Derivative | 6,666 | Not disclosed Strike: $9.30 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 3 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires 2033-03-16 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F4 · derivative.exercise_date: These performance-based stock options, granted on March 16, 2023, vest when the achievement of certain clinical and regulatory development milestones are met. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | Disposition to issuerStock Option (right to buy) · Derivative | 13,332 | Not disclosed Strike: $9.30 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 2 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,332 shares Expires 2033-03-16 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F3 · derivative.exercise_date: The shares subject to this option vest in approximately equal monthly installments beginning on April 1, 2023 through April 1, 2027. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 00:22 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | Disposition to issuerStock Option (right to buy) · Derivative | 15,332 | Not disclosed Strike: $33.45 | Not disclosed |
DisclosureSEC source: 0000950170-23-063926 · ownership.xml · derivative · entry 1 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,332 shares Expires 2032-03-03 F1 · derivative.exercise_price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F1 · price: In accordance with the terms of the Synlogic, Inc. 2015 Equity Incentive Award Plan and the Company's 2017 Stock Incentive Plan (together the "Plans"), the Board of Directors of Synlogic, Inc. approved a stock option repricing pursuant to which option awards granted under the Plans were amended to reduce the exercise price to $1.85 per share, the closing stock price of the Company's Common Stock on November 10, 2023. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements. F2 · derivative.exercise_date: These stock options vested 25% on the first anniversary of the March 3, 2022 grant date, and vest in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:15 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | SaleCommon Stock | 2,553 | $0.58 | $1,470.02 |
DisclosureSEC source: 0000899243-23-010714 · doc4.xml · nonDerivative · entry 1 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,947 F1 · shares: Represents the number of shares sold by the reporting person on April 3, 2023 to cover the tax liability in connection with the vesting of a restricted stock award, vesting on April 1, 2023, that was granted in 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5750 to $0.5798, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,000 shares acquired on September 30, 2022 and 5,000 shares acquired on March 31, 2023 under the Synlogic, Inc. 2015 Employee Stock Purchase Plan. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:10 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | PurchaseCommon Stock | 9,500 | $1.12 | $10,640.00 |
DisclosureSEC source: 0000899243-22-019461 · doc4.xml · nonDerivative · entry 1 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,500 Read SEC document |
| March 03, 2022 Filed Mar 3, 2022 22:07 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | GrantStock Option (right to buy) · Derivative | 230,000 | $0.00 Strike: $2.23 | $0.00 |
DisclosureSEC source: 0000899243-22-009122 · doc4.xml · derivative · entry 2 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Underlying: Common Stock · 230,000 shares Expires 2032-03-03 F2 · derivative.exercise_date: The options were granted on March 3, 2022, and will vest 25% on the first anniversary of the date of grant and the remaining options will vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person continuing to provide services to the Issuer as Chief Financial Officer through each such vesting date. Read SEC document |
| March 03, 2022 Filed Mar 3, 2022 22:07 UTC | SYNLOGIC, INC. SYBX · Entity 7801 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009122 · doc4.xml · nonDerivative · entry 1 JENSEN MICHAEL VANGSTED · CIK 0001914184 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: The shares of restricted stock were granted on March 3, 2022, and will vest in four equal annual installments on each of the first four anniversaries of April 1, 2022, subject to the Reporting Person continuing to provide services to the Issuer as Chief Financial Officer through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.